Biotech Values

[iandy]

SGYP - FiercePharma - Synergy preps for Trulance launch with competitive pricing, experienced GI reps
by Carly Helfand | Mar 6, 2017 9:05am

>Synergy will be doing it all with a “hybrid” commercialization strategy, incorporating both company-hired regional sales managers and account specialists, along with contract reps. Archila estimates the drugmaker’s ranks will boast between 200 and 300 reps at launch, all with “significant GI experience.”<

http://www.fiercepharma.com/marketing/synergy-preps-for-constipation-market-assault-competitive-trulance-price-experienced-reps

I think they will do OK once the drug is on the market a year. On paper the efficacy is similar and the tolerability
is much better than Linzess. Of course they don't have the cash to promote the drug as well as Allergan but once the specialists are familiar you could have patients asking for Linzess and ending up with scripts for Trulance.